Status:
COMPLETED
Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients
Lead Sponsor:
HonorHealth Research Institute
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
60-100 years
Phase:
PHASE2
Brief Summary
This study will evaluate the administration of N-Acetyl-cysteine in combination with multi-vitamins/minerals in geriatric population (\>60 years of age) who have experienced a traumatic brain injury.
Detailed Description
This study aims to determine the effect of supplemental N-acetyl cysteine and additional multi-vitamin/mineral therapy on somatic, cognitive, and emotional post-concussion symptoms as determined by th...
Eligibility Criteria
Inclusion
- 60 years or older
- present to emergency department within 3 hours of documented TBI
Exclusion
- patients without TBI
- patients with a history of TBI greater than 3 hours prior to presentation
- patients under the age of 60
- currently enrolled in an ongoing research study
- patients who at baseline prior to the TBI, cannot participate in cognitive function testing (aphasia, severe dementia, non verbal; prior to TBI)
- Patients who are unable to tolerate PO medications within 3 hours of sustaining TBI.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04291066
Start Date
September 1 2019
End Date
August 1 2021
Last Update
September 1 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
HonorHealth John C. Lincoln Medical Center
Phoenix, Arizona, United States, 85020
2
HonorHealth Deer Valley Medical Center
Phoenix, Arizona, United States, 85027